Several April releases seem to signal some basis for optimism for stakeholders in Medicare Advantage and Part D, though with sufficient undertones to recommend caution. Of particular note, the CY 2026 ...

McDermott+ is pleased to bring you Regs & Eggs, a weekly Regulatory Affairs blog by Jeffrey Davis. CMS proposes two important changes to the Star Ratings system that, if finalized, would have ...